Bavarian Nordic’s Post

Today we turn 30! 🎉 When Bavarian Nordic was established on October 6, 1994, we had a clear but ambitious vision: Developing vaccines that would safeguard the health of people around the world. Over the past weeks, we have asked colleagues to share their stories on pivotal moments shaping the Bavarian Nordic we know today.  What began as a small, determined group with a bold idea has over the past three decades transformed into a global leader in vaccine innovation. Thank you to former and present colleagues for creating a purposeful company that saves and protects lives. Here’s to the next 30 years of innovation, impact, and success! Jane Maclennan Kirsten Lyng Hundrup Hubertus Hochrein Jürgen Hausmann Jean-Christophe (JC) May Bernard Hoet Victoria Mira (née Jenkins) Tatyana Tyx and many more.

🌍✈️ This #WorldRabiesDay, we’re thrilled to partner with Global Alliance for Rabies Control (GARC) to amplify the voices of Rabies Ambassadors! Whether you’re planning your next adventure or working in high-risk areas, it’s crucial to be aware of the risks of #rabies and the importance of travel vaccines as well as avoiding any contact with unknown animals while on your trip. GARC's #RabiesAmbassadors are raising awareness and sharing their experiences to help protect you and your loved ones. Join us in spreading the word and ensuring everyone stays safe while exploring the world. Stay informed, stay protected, and let’s break rabies boundaries together! 💉🐾 #EndRabiesNow #WRD2024 #TravelSafe

Today is #WorldRabiesDay, and at Bavarian Nordic, we are proud to join forces with the Global Alliance for Rabies Control (GARC) to dispel misconceptions and raise awareness about rabies prevention and treatment. This year’s theme, “Breaking Rabies Boundaries,” emphasizes the importance of overcoming obstacles that hinder our fight against this deadly disease.   Rabies is a viral disease that targets the central nervous system and is transmitted through the bite of an infected animal. However, it is preventable with timely vaccination and medical care. If you’re planning to travel to areas where rabies is prevalent, take proactive steps to protect yourself. Seek pre-travel medical advice, avoid contact with wild animals, and get immediate medical attention if bitten or scratched. Join us in our mission to safeguard travelers worldwide. Learn more about rabies and how to reduce your risk: https://lnkd.in/eVpunwd #EndRabiesNow #WRD2024 #TravelSafe 

Hi, I am Łukasz Szymaszek, and I work as an Associate Director in Global Marketing at Bavarian Nordic. In my job, I need to stay on top of the global market dynamics within vaccines and react to those that may influence us in Bavarian Nordic. I am proud of being a part of Bavarian Nordic because I can see a direct connection in how our work contributes to saving lives and preventing further spread of life-threatening diseases.   If you want to join me at Bavarian Nordic, check out our open positions: https://lnkd.in/eG9TCbF #BavarianNordicDNA #pharma #inclusion #collaboration #boostedbytheteam

Here is to being a persistent pioneer for 30 years! 🥇   While global awareness and demand for mpox vaccines are rising, we remember the very beginnings of bringing our vaccine to market. “Our journey wasn’t just about developing a vaccine—it was about making a lasting impact on public health and protecting lives.” Watch this episode of Jane Maclennan sharing with us the motivation and efforts that led to the development of the smallpox/mpox vaccine.    #BavarianNordic #mpox #vaccine #persistentpioneers #anniversary

Join us at Bavarian Nordic and make a global impact by protecting and saving lives through innovative vaccines! 💉  Be part of an innovative and agile team where you can put your mark and make a difference. Explore career growth opportunities and help us protect tomorrow. 🌍💉 Discover our open positions👉 https://lnkd.in/dh5ZtrkY #PersistentPioneer #Boostedbytheteam 

Today, the European Commission adopted a recommendation from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) to extend the approval of the MVA-BN smallpox and #mpox vaccine to adolescents 12 to 17 years of age. Paul Chaplin, President & CEO of Bavarian Nordic, said: “We applaud EMA for their expedited review and approval of MVA-BN for adolescents. This represents an important milestone in our efforts to make the vaccine available for all populations and will help improve access for some of the most vulnerable individuals mostly impacted by the ongoing mpox outbreak in Africa.” Read the full announcement: https://lnkd.in/d4rdfHej

Today, we announced an advance purchase agreement with Gavi, the Vaccine Alliance to secure 500,000 doses of our #mpox vaccine to be supplied to African countries impacted by the mpox outbreak.   Funded by Gavi’s First Response Fund, established to make cash rapidly available to purchase vaccines in health emergencies, the vaccines will be supplied in 2024, pending the signing of a supply agreement with UNICEF, Gavi’s alliance partner. Commenting on the agreement, Paul Chaplin, President & CEO of Bavarian Nordic, said: “We are pleased to sign this agreement and strengthen our commitment to support Gavi and other global health partners, who have demonstrated strong leadership in making life-saving vaccines available for the vulnerable populations in developing countries for decades. The doses secured through this agreement will significantly increase the availability of mpox vaccines for African countries, and we are pleased that Gavi has selected our vaccine." Read the full announcement: https://lnkd.in/dRHu68yr

Celebrating pivotal moments 🎉 In 2003 we registered our first vaccine against mpox in the US. This was indeed a pivotal moment here at Bavarian Nordic. However, back then we were a much smaller company and therefore bringing a vaccine to the US market, was a huge undertaking, as Kirsten Lyng Hundrup explains:  “Everyone was involved in preparing those massive multi-binder submissions. We had to prove that this little Danish company could handle 20 million doses of a smallpox vaccine that wasn't yet approved. It was quite a challenge but exciting to be a part of.” Meet Kirsten and Andrea, two of our colleagues involved in succeeding with having our MPOX vaccine approved by the US Food and Drug Administration (FDA) in this episode celebrating our anniversary  #BavarianNordic #pioneering #vaccine #savinglives #protectingcommunities

At Bavarian Nordic, we're driven by a relentless pursuit of innovation to help protect lives and improve global health. Our commitment knows no bounds.    #Cholera is endemic to nearly 50 countries across Asia, Africa, and Central and South America. With an increasing number of Canadians visiting these regions, healthcare providers can now offer the only single-dose oral cholera #vaccine to help protect travelers.    This exemplifies our dedication to helping protect lives, expanding access to critical vaccines, and broadening our global footprint.    Learn more: https://lnkd.in/dy_w7rfc #BavarianNordic #Innovation #DiseasePrevention